Literature DB >> 18641347

Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis.

Shuhui Wang1, Thomas Welte, Maureen McGargill, Terrence Town, Jesse Thompson, John F Anderson, Richard A Flavell, Erol Fikrig, Stephen M Hedrick, Tian Wang.   

Abstract

Death-associated protein kinase-related apoptosis-inducing kinase-2 (Drak2), a member of the death-associated protein family of serine/threonine kinases, is specifically expressed in T and B cells. In the absence of Drak2, mice are resistant to experimental autoimmune encephalomyelitis due to a decrease in the number of cells infiltrating the CNS. In the present study, we investigated the role of Drak2 in West Nile virus (WNV)-induced encephalitis and found that Drak2(-/-) mice were also more resistant to lethal WNV infection than wild-type mice. Although Drak2(-/-) mice had an increase in the number of IFN-gamma-producing T cells in the spleen after infection, viral levels in the peripheral tissues were not significantly different between these two groups of mice. In contrast, there was a reduced viral load in the brains of Drak2(-/-) mice, which was accompanied by a decrease in the number of Drak2(-/-) CD4(+) and CD8(+) T cells in the brain following WNV infection. Moreover, we detected viral Ags in T cells isolated from the spleen or brain of WNV-infected mice. These results suggest that following a systemic infection, WNV might cross the blood brain barrier and enter the CNS by being carried by infected infiltrating T cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641347      PMCID: PMC2494872          DOI: 10.4049/jimmunol.181.3.2084

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  West Nile encephalitis: the neuropathology of four fatalities.

Authors:  B A Sampson; V Armbrustmacher
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

2.  A deficiency in Drak2 results in a T cell hypersensitivity and an unexpected resistance to autoimmunity.

Authors:  Maureen A McGargill; Ben G Wen; Craig M Walsh; Stephen M Hedrick
Journal:  Immunity       Date:  2004-12       Impact factor: 31.745

3.  Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay.

Authors:  R S Lanciotti; A J Kerst; R S Nasci; M S Godsey; C J Mitchell; H M Savage; N Komar; N A Panella; B C Allen; K E Volpe; B S Davis; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

4.  West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice.

Authors:  D Ben-Nathan; I Huitinga; S Lustig; N van Rooijen; D Kobiler
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro.

Authors:  John F Anderson; James J Rahal
Journal:  Emerg Infect Dis       Date:  2002-01       Impact factor: 6.883

6.  Fas ligand interactions contribute to CD8+ T-cell-mediated control of West Nile virus infection in the central nervous system.

Authors:  Bimmi Shrestha; Michael S Diamond
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

7.  Flavivirus infection enhancement in macrophages: an electron microscopic study of viral cellular entry.

Authors:  S W Gollins; J S Porterfield
Journal:  J Gen Virol       Date:  1985-09       Impact factor: 3.891

Review 8.  Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Erin Mehlhop; Elizabeth Sitati; Michael Engle
Journal:  Viral Immunol       Date:  2003       Impact factor: 2.257

9.  Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection.

Authors:  William G Glass; Jean K Lim; Rushina Cholera; Alexander G Pletnev; Ji-Liang Gao; Philip M Murphy
Journal:  J Exp Med       Date:  2005-10-17       Impact factor: 14.307

10.  Complement receptor mediates enhanced flavivirus replication in macrophages.

Authors:  M J Cardosa; J S Porterfield; S Gordon
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

View more
  38 in total

Review 1.  Role of γδ T cells in West Nile virus-induced encephalitis: friend or foe?

Authors:  Tian Wang
Journal:  J Neuroimmunol       Date:  2011-11-10       Impact factor: 3.478

2.  gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection.

Authors:  Hao Fang; Thomas Welte; Xin Zheng; Gwong-Jen J Chang; Michael R Holbrook; Lynn Soong; Tian Wang
Journal:  FEMS Immunol Med Microbiol       Date:  2010-02-17

Review 3.  The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.

Authors:  Douglas M Durrant; Soumitra Ghosh; Robyn S Klein
Journal:  ACS Chem Neurosci       Date:  2016-04-08       Impact factor: 4.418

4.  Drak2 is not required for tumor surveillance and suppression.

Authors:  Benjamin A Edwards; Tarsha L Harris; Helen Floersh; John R Lukens; Md Hasan Zaki; Peter Vogel; Thirumala-Devi Kanneganti; Jack D Bui; Maureen A McGargill
Journal:  Int Immunol       Date:  2015-01-07       Impact factor: 4.823

Review 5.  Risk factors for West Nile virus infection and disease in populations and individuals.

Authors:  Ruth R Montgomery; Kristy O Murray
Journal:  Expert Rev Anti Infect Ther       Date:  2015-01-30       Impact factor: 5.091

Review 6.  Viral interactions with the blood-brain barrier: old dog, new tricks.

Authors:  Jianghui Hou; Lane A Baker; Lushan Zhou; Robyn S Klein
Journal:  Tissue Barriers       Date:  2016-01-28

Review 7.  West Nile Virus: biology, transmission, and human infection.

Authors:  Tonya M Colpitts; Michael J Conway; Ruth R Montgomery; Erol Fikrig
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  Oral administration of active hexose correlated compound enhances host resistance to West Nile encephalitis in mice.

Authors:  Shuhui Wang; Thomas Welte; Hao Fang; Gwong-Jen J Chang; Willi K Born; Rebecca L O'Brien; Buxiang Sun; Hajime Fujii; Ken-ichi Kosuna; Tian Wang
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

Review 9.  Age-related alterations in immune responses to West Nile virus infection.

Authors:  R R Montgomery
Journal:  Clin Exp Immunol       Date:  2016-10-17       Impact factor: 4.330

10.  IL-10 signaling blockade controls murine West Nile virus infection.

Authors:  Fengwei Bai; Terrence Town; Feng Qian; Penghua Wang; Masahito Kamanaka; Tarah M Connolly; David Gate; Ruth R Montgomery; Richard A Flavell; Erol Fikrig
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.